Author | Year | Country | Species/gender | Age/weight | I/R duration | Anesthetic | MSCs type /dosage | Administration | Timing of MSCs (post-reperfusion) |
---|---|---|---|---|---|---|---|---|---|
AMI | 2017 | Turkey | SD rats/f | 200–250 g | 45 min/1, 4, 7 d | Xylazine/ketamine | BM, allogeneic, 0.5/1 × 106 | Inferior vena cava/local injection | Immediately |
Chang | 2015 | Taiwan | SD rats/m | 325–350 g | 30 min/3 d | Unclear | AD, autologous, 1.2 × 106 | Intravenous and local injection | Immediately |
Fukuda | 2013 | Japan | ICR mice | Unclear | 60 min/2, 6 h | Unclear | AD, autologous, 1 × 105/106 | i.p | Immediately |
Gao | 2010 | China | Wistar rats/m | ≈ 200 g | 20 min/0.5, 1, 3, 7, 14, 28 d | Unclear | BM, allogeneic, 1 × 106 | Caudal vein | Immediately |
Geng | 2016 | China | SD rats/m | 180–220 g | 30 min/2 h | Unclear | BM, allogeneic, 1 × 107 | Caudal vein | Immediately |
Jensena | 2016 | USA | C57Bl6 mice/m | 8–12 w, 20–30 g | 60 min/12, 24 h | Isoflurane | hAD, 2 × 106 | i.p | Unclear |
Jensenb | 2016 | USA | C57Bl6 mice/m | 8–12 w, 20–30 g | 60 min/12, 24 h | Isoflurane | hAD, hUD, 2 × 106 | i.p | Unclear |
Jensen | 2018 | USA | C57Bl6 mice/m | 8–12 w | 60 min/24 h | Isoflurane | hUD, 2 × 106 | i.p | Immediately |
Jiang | 2011 | China | SD rats/f | 180–200 g | 45 min/4, 7 d | Ketamine | BM, allogeneic (m), 1 × 107 | Local injection | Immediately |
Jiang | 2013 | China | SD rats/f | 180–220 g | 45 min/1, 4, 7 d | Ketamine | BM, allogeneic (m), 1 × 107 | Local injection | Immediately |
Kong | 2020 | China | SD rats/m | 250–300 g | 30 min/72 h | Pentobarbital | AD, allogeneic, 2 × 106 | Caudal vein | Unclear |
Liu | 2016 | China | SD rats | 6–8 w/180–210 g | 30 min/2, 6, 24, 72, 120 h | Unclear | BM, allogeneic, 5 × 106 | Local injection | Unclear |
Liu | 2020 | China | C57Bl6 mice | 20–25 g | 60 min/2 d | Pentobarbital | AD, allogeneic, 5 × 106 | Local injection | Unclear |
Markel | 2015 | USA | C57Bl6 mice/m | 8–12 w/20-30 g | 60 min/6 h | Isoflurane | hBM, 2 × 104/105/106 | i.p | Unclear |
Oliveira | 2018 | Brazil | NZ rabbits | ≈ 10 w/≈ 3 kg | 2 h/3, 7 d | Xylazine, ketamine, tramadol, isoflurane | AD, allogeneic, 1.2 × 106 | Marginal auricular vein | 5 h |
Shen | 2013 | China | SD rats/m | 120–200 g | 30 min/2, 6, 24, 72, 144 h | Chloral hydrate | BM, allogeneic, 1 × 107 | Local injection | Immediately |
Watkins | 2013 | USA | FVB mice/m | 8–10 w/≈ 20 g | 60 min/24 h | Isoflurane | BM/AF (from C57Bl6 mice), 1 × 106 | i.p | 2 h |
Yan | 2019 | China | SD rats/m | unclear | 60 min/1, 7 d | Pentobarbital | BM, allogeneic, 1 × 107 | i.p | Unclear |